Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P1 Receptor Modulator

  • J Med Chem. 2016 Dec 22;59(24):11138-11147. doi: 10.1021/acs.jmedchem.6b01433.
Michael G Yang  1 ,  Zili Xiao  1 ,  T G Murali Dhar  1 ,  Hai-Yun Xiao  1 ,  John L Gilmore  1 ,  David Marcoux  1 ,  Jenny H Xie  1 ,  Kim W McIntyre  1 ,  Tracy L Taylor  1 ,  Virna Borowski  1 ,  Elizabeth Heimrich  1 ,  Yu-Wen Li  1 ,  Jianlin Feng  1 ,  Alda Fernandes  1 ,  Zheng Yang  1 ,  Praveen Balimane  1 ,  Anthony M Marino  1 ,  Georgia Cornelius  1 ,  Bethanne M Warrack  1 ,  Arvind Mathur  1 ,  Dauh-Rurng Wu  1 ,  Peng Li  1 ,  Anuradha Gupta  1 ,  Bala Pragalathan  1 ,  Ding Ren Shen  1 ,  Mary Ellen Cvijic  1 ,  Lois D Lehman-McKeeman  1 ,  Luisa Salter-Cid  1 ,  Joel C Barrish  1 ,  Percy H Carter  1 ,  Alaric J Dyckman  1
Affiliations
  • 1. Research and Development, Bristol-Myers Squibb Company , Princeton, New Jersey 08543-4000, United States.
Abstract

We describe a highly efficient route for the synthesis of 4a (BMS-986104). A key step in the synthesis is the asymmetric hydroboration of trisubstituted alkene 6. Particularly given the known difficulties involved in this type of transformation (6 → 7), the current methodology provides an efficient approach to prepare this class of compounds. In addition, we disclose the efficacy of 4a in a mouse EAE model, which is comparable to 4c (FTY720). Mechanistically, 4a exhibited excellent remyelinating effects on lysophosphatidylcholine (LPC) induced demyelination in a three-dimensional brain Cell Culture assay.

Products